IntraBio Reports Statistically Significant and Clinically Meaningful Improvements in the Use of IB1001 For Treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease)
August 19, 2021
August 19, 2021
August 19, 2021
August 4, 2021
August 3, 2021
July 27, 2021
July 27, 2021
June 10, 2021
June 10, 2021
May 27, 2021
August 27, 2026
Danish biotech company Celvivo adds an industry-veteran investor to its ownership circle and, with its groundbreaking ClinoStar platform for 3D cell c...
August 26, 2026
ALS, also known as Lou Gehrig's disease, is a progressive, fatal neurodegenerative disorder. It progressively damages motor neurons in the brain and s...
August 20, 2026
Laboratory automation veteran brings nearly three decades of commercial and technical leadership to drive growth of Thomas Scientific's technical sale...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225